Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109089) titled 'Effect of Ayurveda medicines in the management of Sickle Cell Disease' on April 22.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Central Council for Research in Ayurvedic Sciences
Condition:
Health Condition 1: D570- Hb-SS disease with crisis
Recruitment Status: Not Recruiting
Phase: Phase 3/ Phase 4
Date of First Enrollment: 01-06-2026
Target Sample Size: 440
Countries of Recruitment:
India
To know more, visit http://www.c...